American Century Companies’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-293,942
Closed -$4.32M 2836
2025
Q3
$4.32M Buy
293,942
+144,924
+97% +$1.48M ﹤0.01% 1777
2025
Q2
$1.46M Sell
149,018
-36,277
-20% -$300K ﹤0.01% 2140
2025
Q1
$1.35M Buy
185,295
+71,726
+63% +$627K ﹤0.01% 2131
2024
Q4
$888K Buy
113,569
+31,564
+38% +$260K ﹤0.01% 2299
2024
Q3
$607K Buy
82,005
+18,141
+28% +$153K ﹤0.01% 2405
2024
Q2
$512K Buy
63,864
+43,842
+219% +$391K ﹤0.01% 2428
2024
Q1
$233K Buy
20,022
+8,659
+76% +$95.9K ﹤0.01% 2727
2023
Q4
$127K Buy
+11,363
New +$104K ﹤0.01% 2783
2023
Q3
Sell
-23,223
Closed -$440K 2862
2023
Q2
$440K Buy
+23,223
New +$408K ﹤0.01% 2274

Other funds holding ETNB

American Century Companies's ETNB Position: Q4 2025 in Review

American Century Companies sold out of 89bio (ETNB) in Q4 2025, closing a stake of 293,942 shares — an estimated $4.32M sold.

American Century Companies first reported a position in ETNB in Q2 2023 and held it in 9 quarters. The position peaked at $4.32M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • American Century Companies reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • American Century Companies sold 293,942 89bio shares in Q4 2025, an estimated $4.32M.
  • American Century Companies first reported a position in 89bio in Q2 2023 and held it in 9 quarters.
  • American Century Companies's 89bio position peaked at $4.32M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.